Xu R - Search Results

1

Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer.

Qin S, Li J, Bai Y, Wang Z, Chen Z, Xu R, Xu J, Zhang H, Chen J, Yuan Y, Liu T, Yang L, Zhong H, Chen D, Shen L, Hao C, Fu D, Cheng Y, Yang J, Wang Q, Qin B, Pan H, Zhang J, Bai X, Zheng Q. Qin S, et al. Among authors: xu r, xu j. J Clin Oncol. 2023 Nov 20;41(33):5163-5173. doi: 10.1200/JCO.22.02630. Epub 2023 Aug 30. J Clin Oncol. 2023. PMID: 37647576 Free PMC article. Clinical Trial.

2

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer.

Li YH, Luo HY, Wang FH, Wang ZQ, Qiu MZ, Shi YX, Xiang XJ, Chen XQ, He YJ, Xu RH. Li YH, et al. J Cancer Res Clin Oncol. 2010 Apr;136(4):503-10. doi: 10.1007/s00432-009-0682-5. Epub 2009 Sep 24. J Cancer Res Clin Oncol. 2010. PMID: 19777259 Clinical Trial.

3

EGFR fluorescence in situ hybridization pattern of chromosome 7 disomy predicts resistance to cetuximab in KRAS wild-type metastatic colorectal cancer patients.

Li YH, Wang F, Shen L, Deng YM, Shao Q, Feng F, An X, Wang FH, Wang ZQ, Xu RH, Shao JY. Li YH, et al. Clin Cancer Res. 2011 Jan 15;17(2):382-90. doi: 10.1158/1078-0432.CCR-10-0208. Epub 2010 Sep 30. Clin Cancer Res. 2011. PMID: 20884623

4

Impact of KRAS mutation and PTEN expression on cetuximab-treated colorectal cancer.

Li FH, Shen L, Li ZH, Luo HY, Qiu MZ, Zhang HZ, Li YH, Xu RH. Li FH, et al. World J Gastroenterol. 2010 Dec 14;16(46):5881-8. doi: 10.3748/wjg.v16.i46.5881. World J Gastroenterol. 2010. PMID: 21155011 Free PMC article.

5

Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial.

Guan ZZ, Xu JM, Luo RC, Feng FY, Wang LW, Shen L, Yu SY, Ba Y, Liang J, Wang D, Qin SK, Wang JJ, He J, Qi C, Xu RH. Guan ZZ, et al. Chin J Cancer. 2011 Oct;30(10):682-9. doi: 10.5732/cjc.011.10188. Chin J Cancer. 2011. PMID: 21959045 Free PMC article. Clinical Trial.

6

Phase 2 study of capecitabine and irinotecan combination chemotherapy (modified XELIRI regimen) in patients with advanced gastric cancer.

Luo HY, Wang ZQ, Wang FH, Qiu MZ, Teng KY, Ruan DY, He YJ, Li YH, Xu RH. Luo HY, et al. Am J Clin Oncol. 2011 Dec;34(6):555-60. doi: 10.1097/COC.0b013e3181f47ac1. Am J Clin Oncol. 2011. PMID: 22101386 Clinical Trial.

7

HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: a prospective cohort observation.

Qiu MZ, Li Q, Wang ZQ, Liu TS, Liu Q, Wei XL, Jin Y, Wang DS, Ren C, Bai L, Zhang DS, Wang FH, Li YH, Xu RH. Qiu MZ, et al. Int J Cancer. 2014 May 15;134(10):2468-77. doi: 10.1002/ijc.28559. Epub 2013 Nov 8. Int J Cancer. 2014. PMID: 24155030

8

The multicenter, phase II prospective study of paclitaxel plus capecitabine as first-line chemotherapy in advanced gastric carcinoma.

Gong J, Hu B, Zhang X, Zhang F, Zhang J, Xu N, Fan Q, Bai Y, Jiao S, Wang J, Bai C, Zheng L, Shi Y, Liu Y, Liang J, Hu G, Cheng Y, Xu R, Bai Y, Shen L. Gong J, et al. Among authors: xu n, xu r. Oncologist. 2014 Feb;19(2):173-4. doi: 10.1634/theoncologist.2013-0137. Epub 2014 Jan 23. Oncologist. 2014. PMID: 24457378 Free PMC article. Clinical Trial.

9

Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study).

Shen L, Li J, Xu J, Pan H, Dai G, Qin S, Wang L, Wang J, Yang Z, Shu Y, Xu R, Chen L, Liu Y, Yu S, Bu L, Piao Y. Shen L, et al. Among authors: xu r, xu j. Gastric Cancer. 2015 Jan;18(1):168-76. doi: 10.1007/s10120-014-0351-5. Epub 2014 Feb 21. Gastric Cancer. 2015. PMID: 24557418 Free PMC article. Clinical Trial.

10

Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study.

Satoh T, Xu RH, Chung HC, Sun GP, Doi T, Xu JM, Tsuji A, Omuro Y, Li J, Wang JW, Miwa H, Qin SK, Chung IJ, Yeh KH, Feng JF, Mukaiyama A, Kobayashi M, Ohtsu A, Bang YJ. Satoh T, et al. J Clin Oncol. 2014 Jul 1;32(19):2039-49. doi: 10.1200/JCO.2013.53.6136. Epub 2014 May 27. J Clin Oncol. 2014. PMID: 24868024 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,270 results

Search Page

Filters